Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0MA4F
|
|||
| Drug Name |
GD2-CART01
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Neuroblastoma [ICD-11: 2D11.2] | Phase 1/2 | [1] | |
| Company |
Bambino Gesù Hospital and Research Institute
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ganglioside GD2 (GD2) | Target Info | CAR-T-Cell-Therapy | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03373097) Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.